Edible and medicinal substances can be contaminated by fungi during harvesting, processing, and storage, leading to mycotoxin production and quality deterioration. The distribution of mycotoxigenic fungi in edible and medicinal substances was investigated in this study. Fungi and mycotoxins were detected in 163 commercially available edible and medicinal substances using standard microbiological techniques and high-performance liquid chromatography. A total of 92.0% of samples contained fungi (0.5–5.3 lg colony-forming units (CFU)·g⁻¹); 208 fungal strains belonging to 16 genera were identified, predominantly Aspergillus and Penicillium. Aspergillus section Nigri (30.3%) produced fumonisin B₂, which was distributed mainly in radix and rhizome samples. Thirteen samples had mycotoxins, of which ochratoxin A was the most common, followed by aflatoxins and zearalenone (ZEN). One Nelumbinis semen sample contained 10.75 μg·kg⁻¹ AFB₁, and one Raisin tree semen sample contained 484.30 μg·kg⁻¹ ZEN, which exceeded regulatory limits in Europe and China. These findings highlight the potential risks associated with fungal contamination and mycotoxins in edible and medicinal substances. Enhanced quality control measures are essential to reduce contamination during harvesting, processing, and storage. Expanded mycotoxin screening, improved preservation techniques, and stricter regulatory standards need to be implemented to ensure consumer safety.

Background: The issue of Helicobacter pylori (H. pylori) resistance to clarithromycin (CLR) has consistently posed challenges for clinical treatment. Hence, a rapid susceptibility testing (AST) method urgently needs to be developed. Methods: In the present study, 35 isolates of H. pylori were isolated from 203 gastritis patients of the Guangzhou cohort, and the antimicrobial resistance phenotypes were associated with their genomes to analyze the relevant mutations. Based on these mutations, a rapid detection system utilizing high-resolution melting (HRM) curve analysis was designed and verified by the Shenzhen cohort, which consisted of 38 H. pylori strains. Results: Genomic analysis identified the mutation of the 2143 allele from A to G (A2143G) of 23S rRNA as the most relevant mutation with CLR resistance (p < 0.01). In the HRM system, the wild-type H. pylori showed a melting temperature (Tm) of 79.28 ± 0.01 °C, while the mutant type exhibited a Tm of 79.96 ± 0.01 °C. These differences enabled a rapid distinction between two types of H. pylori (p < 0.01). Verification examinations showed that this system could detect target DNA as low as 0.005 ng/μL in samples without being affected by other gastric microorganisms. The method also showed a good performance in the Shenzhen validation cohort, with 81.58% accuracy, and 100% specificity. Conclusions: We have developed an HRM system that can accurately and quickly detect CLR resistance in H. pylori. This method can be directly used for the detection of gastric microbiota samples and provides a new benchmark for the simple detection of H. pylori resistance.

Cronobacter spp. are emerging foodborne pathogens that cause severe diseases. However, information on Cronobacter contamination in quick-frozen foods in China is limited. Therefore, we studied the prevalence, molecular characterization, and antimicrobial susceptibility of Cronobacter in 576 quick-frozen food samples collected from 39 cities in China. Cronobacter spp. were found in 18.75% (108/576) of the samples, and the contamination degree of the total positive samples was 5.82 MPN/g. The contamination level of frozen flour product samples was high (44.34%). Among 154 isolates, 109 were C. sakazakii, and the main serotype was C. sakazakii O1 (44/154). Additionally, 11 serotypes existed among four species. Eighty-five sequence types (STs), including 22 novel ones, were assigned, indicating a relatively high genetic diversity of the Cronobacter in this food type. Pathogenic ST148, ST7, and ST1 were the main STs in this study. ST4, epidemiologically related to neonatal meningitis, was also identified. All strains were sensitive to cefepime, tobramycin, ciprofloxacin, and imipenem, in which the resistance to cephalothin was the highest (64.94%).Two isolates exhibited multidrug resistance to five and seven antimicrobial agents, respectively. In conclusion, these findings suggest that the comparatively high contamination level of Cronobacter spp. in quick-frozen foods is a potential risk warranting public attention.

Staphylococcus aureus, as a critical zoonotic and foodborne pathogen, not only triggers public health threats such as food poisoning but also acts as a leading cause of diverse clinical infections, including skin infections, pneumonia, and endocarditis. Confronted with the growing crisis of multidrug resistance in S. aureus, both phage therapy and probiotic therapy have emerged as promising alternative biological strategies; however, the current literature predominantly examines them in isolation. This review therefore aims to delineate the contemporary therapeutic challenges of drug-resistant S. aureus and to systematically compare the mechanisms and clinical translation of phages and probiotics within an integrated analytical framework. We first outline the current therapy landscape, then present side by side the molecular inhibitory mechanisms and clinical progress of both approaches, followed by a comparative analysis of their antibacterial mechanisms, clinical efficacy, and industrial challenges. Through this consolidated perspective, the review not only clarifies the distinct strengths and limitations of each strategy but also seeks to provide researchers and clinicians with a comprehensive mechanistic and evidence-based reference for developing novel antibacterial technologies and designing innovative therapeutic regimens. Ultimately, it highlights potential synergies between phages and probiotics, offering a forward-looking roadmap to overcome S. aureus resistance and advance personalized combinatorial therapies.

The growing global protein demand and environmental concerns from conventional animal agriculture have driven the exploration of sustainable alternative protein sources. Single-cell proteins (SCPs) from microbial fermentation offer a promising solution. This study comprehensively evaluated the nutritional value and safety profile of SCP produced from Ralstonia eutropha H16 through integrated in vitro and in vivo assessments. Nutritional analyses revealed a high crude protein content of 71.87 ± 5.05 g/100 g dry weight, with total amino acids of 53.67 ± 1.05 g/100 g. The essential amino acid content was 24.38 ± 0.51 g/100 g, accounting for 45% of the total amino acids. An essential amino acid index (EAAI) of 1.46 ± 0.04 and an amino acid score (AAS) of 0.83 ± 0.06 confirmed its classification as a high-quality protein source according to FAO/WHO standards. In vivo rat feeding trials demonstrated an adjusted protein efficiency ratio (PER) of 1.81, exceeding common plant proteins such as wheat (0.8–1.1). True digestibility (TD) reached 85.73%, with a biological value (BV) of 49.37%, net protein utilization (NPU) of 42.33%, and protein digestibility-corrected amino acid score (PDCAAS) of 0.71. Comprehensive safety assessments included chemical contaminant screening, acute oral toxicity studies in rats and mice, in vitro chromosome aberration tests, and erythrocyte micronucleus tests. Heavy metals and aflatoxin B₁ levels were below regulatory limits. Acute oral toxicity studies established LD₅₀ values exceeding 10,000 mg/kg body weight in both rodent species, classifying this protein source as practically non-toxic. The 28-day sub-acute toxicity study showed no significant adverse effects at low doses (6.25% protein replacement). Both genotoxicity assays (mammalian cell chromosome aberration assay and mammalian erythrocyte micronucleus test) returned negative results. These findings establish R. eutropha H16-derived SCP as a safe, nutritious, and sustainable protein source with considerable potential for feed and food applications, contributing to global food security and environmental sustainability.

Background . Helicobacter pylori infection is a major risk factor for gastric cancer (GC), especially in East Asia. However, the mechanisms through which bacterial strain heterogeneity contributes to GC risk remain poorly understood. This study aims to elucidate the roles of specific virulence factors, antibiotic resistance profiles and genetic variations in H. pylori in GC development. Methods. We integrated host clinical data with phenotypic and genomic analyses of 31 clinical H. pylori isolates. Genomic analysis was performed to determine phylogenetic lineage and virulence markers. Antibiotic susceptibility and biofilm-forming ability of the clinical isolates were also assessed, and a genome-wide association study (GWAS) was employed to identify genetic polymorphisms linked to GC risk. Results. Among the isolates, 93.5 % of isolates belonged to the East Asian lineage and carried high-risk virulence markers ( cagA EPIYA-ABD, vacA s1m1). However, multidrug resistance was observed in 64.5 % of isolates, with high resistance rates to metronidazole (71.0%) and levofloxacin (48.4%) exceeding global averages. Strong biofilm-forming strains were significantly associated with tetracycline resistance compared to weak biofilm-forming strains. Additionally, GWAS identified five SNPs significantly associated with GC risk, with variants in hemC , babB and C694_RS04850 being enriched in high-risk strains. Conclusions. This study demonstrates the critical impact of H. pylori strain diversity in GC development, emphasizing the necessity for region-specific surveillance and innovative therapeutic strategies.